135 related articles for article (PubMed ID: 38805906)
1. The Glabridin from Huangqin Decoction Prevents the Development of Ulcerative Colitis into Colitis-Associated Colorectal Cancer by Modulating MMP1/MMP3 Activity.
Li R; Chi H; Liao X; Cen S; Zou Y
Int Immunopharmacol; 2024 Jun; 135():112262. PubMed ID: 38805906
[TBL] [Abstract][Full Text] [Related]
2. Effects of Huangqin Decoction on ulcerative colitis by targeting estrogen receptor alpha and ameliorating endothelial dysfunction based on system pharmacology.
Li MY; Li MX; Xu N; Li ZH; Zhang YM; Gan YX; Luo HJ; Zhou CL; Liu YH; Su ZR; Huang XQ; Zheng XB
J Ethnopharmacol; 2021 May; 271():113886. PubMed ID: 33524513
[TBL] [Abstract][Full Text] [Related]
3. Protective effects of Huangqin Decoction against ulcerative colitis and associated cancer in mice.
Chen G; Yang Y; Hu C; Cheng X; Xu Y; Cai X; Wang M; Yang CS; Cao P
Oncotarget; 2016 Sep; 7(38):61643-61655. PubMed ID: 27557503
[TBL] [Abstract][Full Text] [Related]
4. Comparison of the molecular mechanisms of Fuzi Lizhong Pill and Huangqin decoction in the treatment of the cold and heat syndromes of ulcerative colitis based on network pharmacology.
Hu X; Liu W; He M; Qiu Q; Zhou B; Liu R; Wu F; Huang Z
Comput Biol Med; 2023 Jun; 159():106870. PubMed ID: 37084637
[TBL] [Abstract][Full Text] [Related]
5. Integrated Network Pharmacology, Molecular Docking and Animal Experiment to Explore the Efficacy and Potential Mechanism of Baiyu Decoction Against Ulcerative Colitis by Enema.
Cui Y; Hu J; Li Y; Au R; Fang Y; Cheng C; Xu F; Li W; Wu Y; Zhu L; Shen H
Drug Des Devel Ther; 2023; 17():3453-3472. PubMed ID: 38024534
[TBL] [Abstract][Full Text] [Related]
6. Integrated bioinformatics and network pharmacology to identify the therapeutic target and molecular mechanisms of Huangqin decoction on ulcerative Colitis.
Wu Y; Liu X; Li G
Sci Rep; 2022 Jan; 12(1):159. PubMed ID: 34997010
[TBL] [Abstract][Full Text] [Related]
7. Mechanisms of Si-Wu Decoction in the treatment of ulcerative colitis revealed by network pharmacology and experimental verification.
Wang L; Liu Y; Shen G; He G; Qiu S; Li B
J Ethnopharmacol; 2023 Dec; 317():116847. PubMed ID: 37356743
[TBL] [Abstract][Full Text] [Related]
8. Investigation of the Active Ingredients and Mechanism of Hudi Enteric-Coated Capsules in DSS-Induced Ulcerative Colitis Mice Based on Network Pharmacology and Experimental Verification.
Ding P; Liu J; Li Q; Lu Q; Li J; Shi R; Shi L; Mao T; Ge D; Niu H; Peng G; Wang Z
Drug Des Devel Ther; 2021; 15():4259-4273. PubMed ID: 34675488
[TBL] [Abstract][Full Text] [Related]
9. Huangqin decoction ameliorates DSS-induced ulcerative colitis: Role of gut microbiota and amino acid metabolism, mTOR pathway and intestinal epithelial barrier.
Li MX; Li MY; Lei JX; Wu YZ; Li ZH; Chen LM; Zhou CL; Su JY; Huang GX; Huang XQ; Zheng XB
Phytomedicine; 2022 Jun; 100():154052. PubMed ID: 35344714
[TBL] [Abstract][Full Text] [Related]
10. Identification of Active Compounds and Mechanism of Huangtu Decoction for the Treatment of Ulcerative Colitis by Network Pharmacology Combined with Experimental Verification.
Chen W; He L; Zhong L; Sun J; Zhang L; Wei D; Wu C
Drug Des Devel Ther; 2021; 15():4125-4140. PubMed ID: 34616145
[TBL] [Abstract][Full Text] [Related]
11. Network pharmacology and molecular docking-based analyses to predict the potential mechanism of Huangqin decoction in treating colorectal cancer.
Li YJ; Tang DX; Yan HT; Yang B; Yang Z; Long FX
World J Clin Cases; 2023 Jul; 11(19):4553-4566. PubMed ID: 37469733
[TBL] [Abstract][Full Text] [Related]
12. Huangqin Decoction ameliorates ulcerative colitis by regulating fatty acid metabolism to mediate macrophage polarization via activating FFAR4-AMPK-PPARα pathway.
Li MY; Wu YZ; Qiu JG; Lei JX; Li MX; Xu N; Liu YH; Jin Z; Su ZR; Lee SM; Zheng XB; Xiao-Qi H
J Ethnopharmacol; 2023 Jul; 311():116430. PubMed ID: 36997133
[TBL] [Abstract][Full Text] [Related]
13. Network pharmacology dissection of multiscale mechanisms for jiaoqi powder in treating ulcerative colitis.
Wen S; Zhong Z; He L; Zhao D; Chen X; Mi H; Liu F
J Ethnopharmacol; 2021 Jul; 275():114109. PubMed ID: 33845143
[TBL] [Abstract][Full Text] [Related]
14. Based on Network Pharmacology to Explore the Molecular Targets and Mechanisms of Gegen Qinlian Decoction for the Treatment of Ulcerative Colitis.
Wei M; Li H; Li Q; Qiao Y; Ma Q; Xie R; Wang R; Liu Y; Wei C; Li B; Zheng C; Sun B; Yu B
Biomed Res Int; 2020; 2020():5217405. PubMed ID: 33299870
[TBL] [Abstract][Full Text] [Related]
15. Study on the mechanism of Huangqin Decoction on rats with ulcerative colitis of damp-heat type base on mtDNA, TLR4, p-PI3K, p-Akt protein expression and microbiota.
Zheng Y; Liang C; Li Z; Chen J; Chen Z; Jiang Y; Dong Q; Xiao Y; Fu C; Liao W; Yuan X
J Ethnopharmacol; 2022 Sep; 295():115356. PubMed ID: 35568112
[TBL] [Abstract][Full Text] [Related]
16. [Pharmacological effects of Huangqin Decoction prepared from roots of multi-originated peony on ulcerative colitis in mice:a comparative study].
Yang JY; DU K; Yang L; Wang ZT; Wang R; Shi YH
Zhongguo Zhong Yao Za Zhi; 2021 Dec; 46(24):6395-6402. PubMed ID: 34994131
[TBL] [Abstract][Full Text] [Related]
17. The chemical constituents and metabolite profiles of Huangqin decoction in normal and ulcerative colitis rats by UHPLC-Q-TOF/MS analysis.
Tang X; Cui Y; Feng B
J Pharm Biomed Anal; 2024 Jan; 237():115763. PubMed ID: 37813075
[TBL] [Abstract][Full Text] [Related]
18. Huang Qin Decoction inhibits the initiation of experimental colitis associated carcinogenesis by controlling the PAD4 dependent NETs.
Pan Z; Xie X; Chen Y; Pan S; Wu Z; Yang C; Liang J; Zhang M; Wang Q; Chen J; Zhou L; Luo X
Phytomedicine; 2022 Dec; 107():154454. PubMed ID: 36155218
[TBL] [Abstract][Full Text] [Related]
19. Novel applications of Yinhua Miyanling tablets in ulcerative colitis treatment based on metabolomics and network pharmacology.
Wang C; Yu H; Li Z; Wu J; Gao P; He S; Tang D; Wang Q; Liu H; Lv H; Liu J
Phytomedicine; 2024 Jun; 128():155366. PubMed ID: 38537445
[TBL] [Abstract][Full Text] [Related]
20. Identification of Novel Core Genes Involved in Malignant Transformation of Inflamed Colon Tissue Using a Computational Biology Approach and Verification in Murine Models.
Markov AV; Savin IA; Zenkova MA; Sen'kova AV
Int J Mol Sci; 2023 Feb; 24(5):. PubMed ID: 36901742
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
